Search

Avita secures $5m facility for ReCell

Avita Medical has secured a $5 million funding facility from Melbourne-based Fortrend Securities for its skin injury device as part of a strategy to accelerate sales in Europe.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 28/09/18

1 year TSR5 year TSR
107thAvita Medical78%-0%
223rdI Synergy Group31%0%
325thKatana Capital12%4%
349thMustera Property Group6%0%
714thAdmedus-48%-31%
739 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

29/12/17
$75k Bought
29/12/17
$10k Bought
28/12/17
$5k Bought
Total value as at the date of the transaction
Source: Morningstar

Revenue

84th↓Admedus$11.7m
85th↑Mustera Property Group$11.4m
86th↑Avita Medical$11.3m
87th↑I Synergy Group$10.8m
88th↑Katana Capital$10.3m
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer